Back to top

Merrimack Pharmaceuticals (MACK) Jumps: Stock Rises 6.6%
December 03, 2013

Read MoreHide Full Article
Merrimack Pharmaceuticals, Inc. ((MACK - Free Report) ) was a big mover last session, as the company saw its shares rise by roughly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 72% in the past one-month time frame.

This biotechnology company has seen four negative revisions over the last 30 days and its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Merrimack Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Some better-ranked bio-med stocks include Actelion Ltd. (), AMAG Pharmaceuticals, Inc. ((AMAG - Free Report) ) and Heska Corporation ((HSKA - Free Report) ). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Merrimack Pharmaceuticals, Inc. (MACK) - free report >>

AMAG Pharmaceuticals, Inc. (AMAG) - free report >>

Heska Corporation (HSKA) - free report >>

More from Zacks Tale of the Tape

You May Like